Drugs for Psoriatic Arthritis

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2019年 / 61卷 / 1588期
关键词：
NECROSIS-FACTOR INHIBITORS; DOUBLE-BLIND; CONTROLLED-TRIAL; RADIOGRAPHIC PROGRESSION; MONOCLONAL-ANTIBODY; INADEQUATE RESPONSE; PHASE-III; PLACEBO; APREMILAST; MULTICENTER;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：203 / 210
页数：8
相关论文
共 50 条
  • [1] Emerging drugs for psoriatic arthritis
    Caso, Francesco
    Del Puente, Antonio
    Peluso, Rosario
    Caso, Paolo
    Girolimetto, Nicolo
    Del Puente, Aurora
    Scarpa, Raffaele
    Costa, Luisa
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (01) : 69 - 79
  • [2] Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis
    Gladman, Dafna D.
    Orbai, Ana-Maria
    Gomez-Reino, Juan
    Chang-Douglass, Stacey
    Leoncini, Emanuele
    Burton, Hannah E.
    Kanik, Keith S.
    Belen Romero, Ana
    Cappelleri, Joseph C.
    Hsu, Ming-Ann
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2020, 93
  • [3] Precision medicine using molecular-target drugs in psoriatic arthritis
    Miyagawa, Ippei
    Tanaka, Yoshiya
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2025, 17
  • [4] Investigational drugs for treating psoriatic arthritis
    Sheane, Barry J.
    Chandran, Vinod
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (07) : 1001 - 1016
  • [5] Baseline patient characteristics associated with response to biologic therapy in patients with psoriatic arthritis enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    Karki, Chitra
    Liu, Mei
    Kavanaugh, Arthur
    Ritchlin, Christopher T.
    Doquyen Hoa Huynh
    Palmer, Jacqueline B.
    Greenberg, Jeffrey D.
    RMD OPEN, 2018, 4 (01):
  • [6] Distinguishing rheumatoid arthritis from psoriatic arthritis
    Merola, Joseph F.
    Espinoza, Luis R.
    Fleischmann, Roy
    RMD OPEN, 2018, 4 (02):
  • [7] Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
    Valenzuela, Fernando
    Flores, Rodrigo
    CLINICS, 2021, 76
  • [8] Recommendations of the Mexican College of Rheumatology for the management of psoriatic arthritis
    Casasola-Vargas, Julio
    Flores-Alvarado, Diana
    Silveira, Luis H.
    Sicsik-Ayala, Sandra
    Reyes-Cordero, Greta
    Villanueva Quintero, Guadalupe
    Amaya Guerra, Mario
    Reyes Orozco, Sara G.
    Zazueta Montiel, Beatriz E.
    Hernandez-Paz, Roberto
    Mendoza-Fuentes, Angelica
    Bernard-Medina, Ana G.
    Lopez Rodriguez, Alejandra
    Barbosa Cobos, Rosa E.
    Burgos-Vargas, Ruben
    Pacheco-Tena, Cesar
    REUMATOLOGIA CLINICA, 2021, 17 (10): : 611 - 621
  • [9] Novel Therapeutic Approaches and Treatment Targets for Psoriatic Arthritis
    Benfaremo, Devis
    Paci, Valentino
    Luchetti, Michele Maria
    Gabrielli, Armando
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021, 22 (01) : 85 - 98
  • [10] Emerging drugs for psoriatic arthritis
    Olivieri, Ignazio
    D'Angelo, Salvatore
    Palazzi, Carlo
    Lubrano, Ennio
    Leccese, Pietro
    EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (03) : 399 - 414
12345